Definition
- Acute ST-elevation myocardial infarction (STEMI)
- Characterized by clinical findings of acute infarction and ST-segment elevation on 12-lead electrocardiogram (ECG)
- Generally occurs when coronary blood flow decreases abruptly after a thrombotic occlusion of a coronary artery
- Early identification and reperfusion are critical for reducing morbidity and mortality.
- See Unstable Angina and Non ST Elevation Myocardial Infarction.

Epidemiology
- Incidence
- One of the most common diagnoses in hospitalized patients in industrialized countries
- In the U.S.
- ~650,000 patients have a new acute MI each year.
- ~370,000 are STEMI, and the remainder are nonST-elevation myocardial infarction (NSTEMI).
- 450,000 patients have a recurrent acute MI each year.
- Age
- Incidence increases with advancing age.
- Sex

Risk Factors
- Common
- Age
- Men ≥ 50 years
- Women ≥ 60 years
- Incidence increases with age in both sexes.
- Cigarette smoking
- Hypertension
- Blood pressure ≥ 140/90 mmHg or using antihypertensive medication
- Low high-density lipoprotein cholesterol level
- High low-density lipoprotein cholesterol level
- Diabetes mellitus
- Metabolic syndrome
- Family history of premature coronary heart disease (CHD)
- CHD in male first-degree relative < 55 years
- CHD in female first-degree relative < 65 years
- Lifestyle risk factors
- Obesity (body mass index ≥ 30 kg/m2)
- Physical inactivity
- Unstable angina
- Prinzmetals variant angina
- Less common
- Hypercoagulability
- Collagen vascular disease
- Cocaine abuse
- Intracardiac thrombi or masses that can produce coronary emboli
- Emerging risk factors
- Low levels of vitamin D [1]
- Lipoprotein(a)
- Elevated lipoprotein-associated phospholipase A2
- Prothrombotic factors
- Proinflammatory factors, as reflected in elevated C-reactive protein level
- Impaired glucose tolerance
- Ischemic stroke
- Absolute risk of MI or vascular death after ischemic stroke, even in those without high-risk features, approximates levels used by national organizations to designate groups of patients at high risk of vascular events.
- Medications[2][3]
- Cyclooxygenase (COX)-2 inhibitors
- Several have been discontinued.
- Celecoxib is still in use and under study; drug carries warning that it may increase risk of cardiovascular events.
- Nonselective NSAIDs (controversial)

Etiology
- STEMI usually occurs when coronary blood flow ceases or decreases abruptly, after thrombotic occlusion of a coronary artery previously affected by atherosclerosis.
- In most cases, infarction occurs when an atherosclerotic plaque ruptures or fissures, and when conditions (local or systemic) favor thrombogenesis.
- Mural thrombus forms at the site of rupture and leads to coronary occlusion.
- Histologic studies indicate that the coronary plaques prone to rupture are those with a rich lipid core and a thin fibrous cap.
- In rare cases, STEMI may be due to coronary artery occlusion caused by:
- Coronary emboli
- Congenital abnormalities
- Coronary spasm
- Wide variety of systemicparticularly inflammatorydiseases
- The amount of myocardial damage caused by coronary occlusion depends on:
- The territory supplied by the affected vessel
- Whether or not the vessel becomes totally occluded
- The duration of coronary occlusion
- The quantity of blood supplied by collateral vessels to the affected tissue
- The demand for oxygen of the myocardium, whose blood supply has been suddenly limited
- Native factors that can produce early spontaneous lysis of the occlusive thrombus
- The adequacy of myocardial perfusion in the infarct zone when flow is restored in the occluded epicardial coronary artery
- In up to half of cases, precipitating factors such as the following are implicated in STEMI:
- Vigorous physical exercise
- Emotional stress
- Medical or surgical illness
- Cocaine abuse (rare)
Acute ST Elevation Myocardial Infarction is a sample topic found in
Harrison's Practice.
To find other Harrison's Practice topics
please login or purchase a subscription.